Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency

Biocon said the CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected early next year.

from Industry-Economic Times
Read The Rest:economictimes...